Essential Tremor Clinical Trial
Official title:
Elucidating the Temporality of Structural and Functional Connectivity Changes in Essential Tremor After Successful Deep Brain Stimulation to the Dentato-rubro-thalamic Tract
The purpose of this study is to elucidate the structural connectivity of the dentato-rubro-thalamic tract (DRTt) and to detect functional network changes due to DRTt stimulation
Status | Recruiting |
Enrollment | 72 |
Est. completion date | August 31, 2026 |
Est. primary completion date | August 31, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 85 Years |
Eligibility | Inclusion Criteria: - the diagnosis of Essential Tremor, made by a movement disorder neurologist, where tremor is not secondary to any disease process or traumatic insult - distal appendicular tremor, with minimal proximal component - tremor refractory to multiple medication regimens and/or where the medications cause intolerable side effects - tremor judged to be severely impacting their quality of life. Exclusion Criteria: - significant neurological disorder - significant dementia or neurocognitive limitations as assessed by neuropsychiatry (when necessary) - severe psychiatric illness with suicidal ideations - previous surgery to destroy the target region of the brain - surgical contraindications to DBS - current major medical problems that affect brain anatomy,neurochemistry, or function, e.g., liver insufficiency, kidney insufficiency, cardiovascular problems, systemic infections, cancer, hypothyroidism, auto-immune diseases, and any current of history of brain disorder (seizure disorder, stroke, dementia, meningitis, encephalitis, degenerative neurologic diseases and head injury with loss of consciousness for any period of time) - family history of hereditary neurologic disorder, besides essential tremors ET - floating metallic objects in the body - pregnancy - alcohol or substance abuse/dependence in the past 6 months. |
Country | Name | City | State |
---|---|---|---|
United States | The University of Texas Health Science Center at Houston | Houston | Texas |
Lead Sponsor | Collaborator |
---|---|
Northwell Health | National Institutes of Health (NIH) |
United States,
Conner CR, Forseth KJ, Lozano AM, Ritter R 3rd, Fenoy AJ. Thalamo-cortical evoked potentials during stimulation of the dentato-rubro-thalamic tract demonstrate synaptic filtering. Neurotherapeutics. 2024 Jan;21(1):e00295. doi: 10.1016/j.neurot.2023.10.005 — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Structural connectivity as indicated by fractional anisotropy (FA) as measured by diffusion tensor imaging (DTI) MRI | Baseline before DBS implant | ||
Primary | Structural connectivity as indicated by fractional anisotropy (FA) as measured by diffusion tensor imaging (DTI) MRI | 24 months after start of DBS | ||
Primary | Structural connectivity as indicated by mean diffusivity as measured by diffusion tensor imaging (DTI) MRI | Baseline before DBS implant | ||
Primary | Structural connectivity as indicated by mean diffusivity as measured by diffusion tensor imaging (DTI) MRI | 24 months after start of DBS | ||
Primary | Structural connectivity as indicated by radial diffusivity as measured by diffusion tensor imaging (DTI) MRI | Baseline before DBS implant | ||
Primary | Structural connectivity as indicated by radial diffusivity as measured by diffusion tensor imaging (DTI) MRI | 24 months after start of DBS | ||
Primary | Structural connectivity as indicated by axial diffusivity as measured by diffusion tensor imaging (DTI) MRI | Baseline before DBS implant | ||
Primary | Structural connectivity as indicated by axial diffusivity as measured by diffusion tensor imaging (DTI) MRI | 24 months after start of DBS | ||
Primary | Functional connectivity as indicated by blood oxygen level dependent (BOLD) signal as measured by resting state functional MRI (rsfMRI) | Baseline before DBS implant | ||
Primary | Functional connectivity as indicated by blood oxygen level dependent (BOLD) signal as measured by resting state functional MRI (rsfMRI) | 24 months after start of DBS | ||
Primary | Functional connectivity as indicated by blood oxygen level dependent (BOLD) signal as measured by resting state functional MRI (rsfMRI) | Baseline before DBS is turned off | ||
Primary | Functional connectivity as indicated by blood oxygen level dependent (BOLD) signal as measured by resting state functional MRI (rsfMRI) | 72 hours after DBS is turned off | ||
Primary | Tremor as assessed by score on The Essential Tremor Rating Scale (TETRAS) | 10 items are measured-each is scored from 0-4,higher number indicating more tremor | Baseline before DBS implant | |
Primary | Tremor as assessed by score on The Essential Tremor Rating Scale (TETRAS) | 10 items are measured-each is scored from 0-4,higher number indicating more tremor | 24 months after start of DBS | |
Primary | Tremor as assessed by score on The Essential Tremor Rating Scale (TETRAS) | 10 items are measured-each is scored from 0-4,higher number indicating more tremor | Baseline before DBS is turned off | |
Primary | Tremor as assessed by score on The Essential Tremor Rating Scale (TETRAS) | 10 items are measured-each is scored from 0-4,higher number indicating more tremor | 72 hours after DBS is turned off | |
Primary | Tremor as assessed by score on The Essential Tremor Rating Scale (TETRAS) | 10 items are measured-each is scored from 0-4,higher number indicating more tremor | During DBS placement surgery before active DBS | |
Primary | Tremor as assessed by score on The Essential Tremor Rating Scale (TETRAS) | 10 items are measured-each is scored from 0-4,higher number indicating more tremor | During DBS placement surgery during active DBS | |
Primary | Spectral power recorded during intraoperative electrocorticography (ECoG) | During DBS placement surgery before active DBS | ||
Primary | Spectral power recorded during intraoperative electrocorticography (ECoG) | During DBS placement surgery during active DBS | ||
Secondary | Ataxia as assessed by score on the Scale for the Assessment and Rating of Ataxia (SARA) | It has eight categories with accumulative score ranging from 0 (no ataxia) to 40 (most severe ataxia). | Baseline before DBS implant | |
Secondary | Ataxia as assessed by score on the Scale for the Assessment and Rating of Ataxia (SARA) | It has eight categories with accumulative score ranging from 0 (no ataxia) to 40 (most severe ataxia). | 24 months after start of DBS | |
Secondary | Ataxia as assessed by score on the Scale for the Assessment and Rating of Ataxia (SARA) | It has eight categories with accumulative score ranging from 0 (no ataxia) to 40 (most severe ataxia). | Baseline before DBS is turned off | |
Secondary | Ataxia as assessed by score on the Scale for the Assessment and Rating of Ataxia (SARA) | It has eight categories with accumulative score ranging from 0 (no ataxia) to 40 (most severe ataxia). | 72 hours after DBS is turned off | |
Secondary | Tremor amplitude as assessed by accelerometric power | Baseline before DBS is turned off | ||
Secondary | Tremor amplitude as assessed by accelerometric power | 72 hours after DBS is turned off |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT05381688 -
VIM DBS Respiratory Modulation: N-of-1 Trial
|
||
Recruiting |
NCT05101161 -
Neurofeedback Using Implanted Deep Brain Stimulation Electrodes
|
N/A | |
Completed |
NCT02277106 -
Evaluate SAGE-547 in Participants With Essential Tremor
|
Phase 2 | |
Recruiting |
NCT05769933 -
Bridging Gaps in the Neuroimaging Puzzle: New Ways to Image Brain Anatomy and Function in Health and Disease Using Electroencephalography and 7 Tesla Magnetic Resonance Imaging
|
||
Terminated |
NCT02894567 -
Evaluation of Directional Recording and Stimulation Using spiderSTN
|
N/A | |
Terminated |
NCT02678429 -
Atlas Predicted DBS Settings in Essential Tremor
|
N/A | |
Completed |
NCT02523807 -
Tremor Monitoring Device
|
N/A | |
Active, not recruiting |
NCT02255929 -
Gamma Knife Radiosurgery for Treatment of Essential Tremor
|
N/A | |
Completed |
NCT01223144 -
Decision-making and Emotion Recognition in Essential Tremor
|
N/A | |
Completed |
NCT00906412 -
Ventrointermediate Nucleus (VIM DBS) and Working Memory
|
N/A | |
Recruiting |
NCT05214222 -
Penpulimab Plus Chemotherapy With/Without Anlotinib for Patients With Advanced Esophageal Squamous Cell Carcinoma
|
Phase 2 | |
Completed |
NCT03051178 -
Wearable Sensor for Responsive DBS for ET
|
N/A | |
Recruiting |
NCT03795935 -
Relief From Side Effects: Clinical Use of Electrodes With Direction
|
N/A | |
Not yet recruiting |
NCT06036368 -
Study to Evaluate Safety and Efficacy of Peroneal Transcutaneous NeuroModulation in Subjects With Parkinson's Disease and Essential Tremor
|
N/A | |
Recruiting |
NCT05897775 -
Coordinated Reset Deep Brain Stimulation for Essential Tremor
|
Phase 1 | |
Recruiting |
NCT05968976 -
Multicentre RCT of Awake Versus Asleep Tractography Based DBS for ET
|
N/A | |
Completed |
NCT06314139 -
Tolerability and Efficacy of Continuous Theta-burst Stimulation for Essential Tremor: A Randomized Study.
|
N/A | |
Recruiting |
NCT04501133 -
Sensory-specific Peripheral Stimulation for Tremor Management
|
N/A | |
Active, not recruiting |
NCT03560622 -
Functional Neuroimaging Feedback for Focused Ultrasound Thalamotomy
|
N/A | |
Completed |
NCT00368199 -
Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes
|
N/A |